Earnings upside for this defense giant isn't being appreciated by investors, says UBS

UBS upgraded Lockheed Martin to Buy from Neutral and raised its price target to $674, implying 28% upside from Friday's close; shares gained nearly 1% following the call. UBS forecasts 9% revenue CAGR through 2028, driven by missiles and munitions, F-35 sustainment, CH-53K and Trident programs, with potential double-digit upside to 2028 EPS consensus. The firm also models 38% free-cash-flow growth from 2025 to 2030, arguing the stock's 15% discount to the S&P 500 does not reflect its production and earnings-growth potential.

Analysis

The investable question is not incremental missile demand but whether LMT can convert backlog into cash without the working-capital drag, supplier constraints, and fixed-price execution issues that have historically capped defense-sector upside. If production cadence improves, F-35 sustainment and strategic programs add a higher-visibility, recurring mix that should support both margin durability and a lower perceived cash-flow risk premium. That creates scope for multiple expansion rather than relying solely on estimate revisions.

Near term, the stock is likely sensitive to order-flow headlines but the more durable 1-3 month catalyst is evidence of conversion: quarterly free-cash-flow performance, inventory normalization, and any raised outlook for program deliveries. Over 6-18 months, constrained propulsion, energetics, and electronics capacity could shift procurement dollars toward incumbents with qualified production lines; LMT's advantage is largest where certification barriers limit new entrants. The key second-order risk is that rapid capacity expansion raises capex and working-capital needs faster than contract pricing catches up, leaving EPS growth intact but cash returns disappointing.

Consensus appears to treat the pension-related cash headwind and reduced buyback flexibility as permanent valuation constraints. The contrarian opportunity is that pension funding can de-risk the balance sheet and eliminate a recurring cash-use uncertainty; however, this only merits a rerating if management demonstrates that core-program cash conversion remains resilient after that funding. Falsify the thesis on a material reduction in free-cash-flow guidance, renewed F-35 delivery/sustainment disruption, or evidence that missile output is constrained by suppliers rather than LMT factory capacity.

Key Decisions for Investors

• Initiate a 6-12 month long LMT position on weakness rather than chase analyst-driven strength; target a rerating through the next two earnings prints, with downside defined by a free-cash-flow guidance cut or worsening working-capital build. Risk/reward is favorable only if cash conversion confirms the earnings trajectory.
• Use a long LMT / short ITA pair over 3-6 months for investors seeking to isolate company-specific cash-flow normalization from broad geopolitical-defense beta. The pair should outperform if LMT converts program volume into FCF while smaller defense constituents remain more exposed to supply-chain bottlenecks and lower-margin production ramps.
• Maintain a watch on RTX and GD as read-through comparables rather than immediate shorts: broad missile demand can lift both, but RTX's propulsion exposure and GD's strategic-program mix may signal whether the constraint is demand, supplier capacity, or contract economics. A sector-wide delivery shortfall would weaken the LMT-specific thesis.
• Ahead of the next earnings release, add only if management reaffirms cash-flow delivery while quantifying inventory, capex, and pension cash uses. If reported earnings rise but operating cash flow lags materially, avoid adding: the market is unlikely to reward a backlog story without demonstrated conversion.